Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Watchlist
Price: 29.02 CNY 0.42%
Market Cap: 46.7B CNY
Have any thoughts about
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

11.6
Current
9.4
Median
16.8
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
11.6
=
Enterprise Value
48B CNY
/
EBIT
4.1B CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
10.6
2-Years Forward
EV/EBIT
10.2
3-Years Forward
EV/EBIT
10.3

See Also

Discover More